JP2011528249A - 安全な切除 - Google Patents
安全な切除 Download PDFInfo
- Publication number
- JP2011528249A JP2011528249A JP2011518045A JP2011518045A JP2011528249A JP 2011528249 A JP2011528249 A JP 2011528249A JP 2011518045 A JP2011518045 A JP 2011518045A JP 2011518045 A JP2011518045 A JP 2011518045A JP 2011528249 A JP2011528249 A JP 2011528249A
- Authority
- JP
- Japan
- Prior art keywords
- temperature
- substance
- responsive material
- stimulus
- ablation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002271 resection Methods 0.000 title description 4
- 239000000463 material Substances 0.000 claims abstract description 175
- 239000000126 substance Substances 0.000 claims abstract description 137
- 238000002679 ablation Methods 0.000 claims abstract description 109
- 238000005286 illumination Methods 0.000 claims abstract description 26
- 238000001816 cooling Methods 0.000 claims description 56
- 239000000835 fiber Substances 0.000 claims description 33
- 230000003287 optical effect Effects 0.000 claims description 31
- 238000004140 cleaning Methods 0.000 claims description 19
- 230000007423 decrease Effects 0.000 claims description 12
- 239000012530 fluid Substances 0.000 claims description 11
- 238000010521 absorption reaction Methods 0.000 claims description 7
- 238000005520 cutting process Methods 0.000 claims description 7
- 238000013021 overheating Methods 0.000 description 39
- 239000000017 hydrogel Substances 0.000 description 38
- 238000000034 method Methods 0.000 description 32
- 238000010586 diagram Methods 0.000 description 28
- 239000000178 monomer Substances 0.000 description 26
- 210000001519 tissue Anatomy 0.000 description 21
- 239000000203 mixture Substances 0.000 description 20
- 239000012809 cooling fluid Substances 0.000 description 18
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 13
- 230000008859 change Effects 0.000 description 13
- 230000009931 harmful effect Effects 0.000 description 12
- 230000002262 irrigation Effects 0.000 description 12
- 238000003973 irrigation Methods 0.000 description 12
- 238000010438 heat treatment Methods 0.000 description 11
- 238000005259 measurement Methods 0.000 description 11
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 10
- 230000003902 lesion Effects 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000011521 glass Substances 0.000 description 8
- 239000013077 target material Substances 0.000 description 8
- 206010003658 Atrial Fibrillation Diseases 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- 230000007704 transition Effects 0.000 description 7
- 229910001868 water Inorganic materials 0.000 description 7
- LEJBBGNFPAFPKQ-UHFFFAOYSA-N 2-(2-prop-2-enoyloxyethoxy)ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOC(=O)C=C LEJBBGNFPAFPKQ-UHFFFAOYSA-N 0.000 description 6
- -1 N-substituted acrylamides Chemical class 0.000 description 6
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 210000005003 heart tissue Anatomy 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000007669 thermal treatment Methods 0.000 description 6
- 206010020843 Hyperthermia Diseases 0.000 description 5
- 230000006399 behavior Effects 0.000 description 5
- 230000036031 hyperthermia Effects 0.000 description 5
- 229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- 239000000376 reactant Substances 0.000 description 5
- 230000004936 stimulating effect Effects 0.000 description 5
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 4
- 239000004971 Cross linker Substances 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 238000004590 computer program Methods 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 206010016717 Fistula Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 210000003238 esophagus Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000003890 fistula Effects 0.000 description 3
- 239000003999 initiator Substances 0.000 description 3
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000012780 transparent material Substances 0.000 description 3
- CCJAYIGMMRQRAO-UHFFFAOYSA-N 2-[4-[(2-hydroxyphenyl)methylideneamino]butyliminomethyl]phenol Chemical compound OC1=CC=CC=C1C=NCCCCN=CC1=CC=CC=C1O CCJAYIGMMRQRAO-UHFFFAOYSA-N 0.000 description 2
- MXRGSJAOLKBZLU-UHFFFAOYSA-N 3-ethenylazepan-2-one Chemical compound C=CC1CCCCNC1=O MXRGSJAOLKBZLU-UHFFFAOYSA-N 0.000 description 2
- FLCAEMBIQVZWIF-UHFFFAOYSA-N 6-(dimethylamino)-2-methylhex-2-enamide Chemical compound CN(C)CCCC=C(C)C(N)=O FLCAEMBIQVZWIF-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000037656 Respiratory Sounds Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000000110 cooling liquid Substances 0.000 description 2
- 238000007334 copolymerization reaction Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000007373 indentation Methods 0.000 description 2
- 238000000608 laser ablation Methods 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920000671 polyethylene glycol diacrylate Polymers 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical group C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- JWYVGKFDLWWQJX-UHFFFAOYSA-N 1-ethenylazepan-2-one Chemical compound C=CN1CCCCCC1=O JWYVGKFDLWWQJX-UHFFFAOYSA-N 0.000 description 1
- OSSNTDFYBPYIEC-UHFFFAOYSA-N 1-ethenylimidazole Chemical compound C=CN1C=CN=C1 OSSNTDFYBPYIEC-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- DPBJAVGHACCNRL-UHFFFAOYSA-N 2-(dimethylamino)ethyl prop-2-enoate Chemical compound CN(C)CCOC(=O)C=C DPBJAVGHACCNRL-UHFFFAOYSA-N 0.000 description 1
- GYHZLNKMZPYTFB-UHFFFAOYSA-N 2-(oxiran-2-yl)acetamide Chemical compound NC(=O)CC1CO1 GYHZLNKMZPYTFB-UHFFFAOYSA-N 0.000 description 1
- GJKGAPPUXSSCFI-UHFFFAOYSA-N 2-Hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone Chemical compound CC(C)(O)C(=O)C1=CC=C(OCCO)C=C1 GJKGAPPUXSSCFI-UHFFFAOYSA-N 0.000 description 1
- LCZVSXRMYJUNFX-UHFFFAOYSA-N 2-[2-(2-hydroxypropoxy)propoxy]propan-1-ol Chemical compound CC(O)COC(C)COC(C)CO LCZVSXRMYJUNFX-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- LPNSCOVIJFIXTJ-UHFFFAOYSA-N 2-methylidenebutanamide Chemical compound CCC(=C)C(N)=O LPNSCOVIJFIXTJ-UHFFFAOYSA-N 0.000 description 1
- AGBXYHCHUYARJY-UHFFFAOYSA-N 2-phenylethenesulfonic acid Chemical compound OS(=O)(=O)C=CC1=CC=CC=C1 AGBXYHCHUYARJY-UHFFFAOYSA-N 0.000 description 1
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- IMYPFLGRAGCVPU-UHFFFAOYSA-N 3-(hydroxymethyl)-2-methylhex-2-enamide Chemical compound CCCC(CO)=C(C)C(N)=O IMYPFLGRAGCVPU-UHFFFAOYSA-N 0.000 description 1
- HIAJGGCEMFIVBO-UHFFFAOYSA-N 3-carbamoyl-4-methylpent-2-enoic acid Chemical compound CC(C)C(C(N)=O)=CC(O)=O HIAJGGCEMFIVBO-UHFFFAOYSA-N 0.000 description 1
- UVRCNEIYXSRHNT-UHFFFAOYSA-N 3-ethylpent-2-enamide Chemical compound CCC(CC)=CC(N)=O UVRCNEIYXSRHNT-UHFFFAOYSA-N 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010016803 Fluid overload Diseases 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 238000013153 catheter ablation Methods 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000011557 critical solution Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 125000004386 diacrylate group Chemical group 0.000 description 1
- GLUUGHFHXGJENI-UHFFFAOYSA-N diethylenediamine Natural products C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 229920001480 hydrophilic copolymer Polymers 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- GVKDCYNVGQYGCX-UHFFFAOYSA-N n-(1-hydroxybutan-2-yl)-2-methylprop-2-enamide Chemical compound CCC(CO)NC(=O)C(C)=C GVKDCYNVGQYGCX-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- UIIIBRHUICCMAI-UHFFFAOYSA-N prop-2-ene-1-sulfonic acid Chemical compound OS(=O)(=O)CC=C UIIIBRHUICCMAI-UHFFFAOYSA-N 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- XUWVIABDWDTJRZ-UHFFFAOYSA-N propan-2-ylazanide Chemical compound CC(C)[NH-] XUWVIABDWDTJRZ-UHFFFAOYSA-N 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000000015 thermotherapy Methods 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B18/24—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B18/28—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor for heating a thermal probe or absorber
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00057—Light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00084—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
- A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
- A61B2018/00023—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids closed, i.e. without wound contact by the fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00666—Sensing and controlling the application of energy using a threshold value
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Electromagnetism (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Optics & Photonics (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Laser Surgery Devices (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Surgical Instruments (AREA)
Abstract
Description
Claims (15)
- 切除エネルギーを物質へ供給する供給ユニットと、刺激反応材料を有する容器とを有し、前記刺激反応材料は、前記物質の温度が前記切断エネルギーのために上限温度を超えて増大する場合、第1の状態から第2の状態へその状態を変化し、前記物質の前記温度が温度限界を超えないようにする、装置。
- 前記刺激反応材料は、前記物質の前記温度が下限温度を下回って減少する場合、第2の状態から第1の状態へその状態を戻すように変化する、請求項1に記載の装置。
- 前記刺激反応材料は、温度感応ゲルである、請求項1に記載の装置。
- 前記供給ユニットが前記刺激反応材料を通じて前記切除エネルギーを供給し、前記刺激反応材料は、前記物質の前記温度が前記上限温度を超えて増大する場合、その光学特性を透明から散乱及び/又は吸収へ変化する、請求項1に記載の装置。
- 前記装置を冷却するための冷却システムを有し、前記刺激反応材料は、前記冷却システムを制御するために、その幾何的特性を変化する、請求項1に記載の装置。
- 前記冷却システムは、少なくとも一つの流入パイプ及び少なくとも一つの流出パイプを有し、前記容器は、前記物質の前記温度が前記上限温度以下である場合、前記少なくとも一つの流入パイプと前記少なくとも一つの流出パイプとの間の接続を少なくとも部分的に不能にし、前記物質の前記温度が前記上限温度を超えて増大する場合、前記接続を可能にする、少なくとも一つのフレキシブル部分を有する、請求項5に記載の装置。
- 前記冷却システムは、前記供給ユニットの周りに延在する少なくとも一部分を有する、請求項5に記載の装置。
- 前記供給ユニットはファイバであり、前記切除エネルギーはレーザーエネルギーである、請求項1に記載の装置。
- 流体を供給する及び/又は流すための洗浄システムを有し、前記刺激反応材料は、前記洗浄システムを制御するためその幾何特性を変化する、請求項1に記載の装置。
- 前記物質を照明するための少なくとも一つの照明ユニットと、前記物質の状態についての情報を得るために、反射光を受けるための少なくとも一つの受光ユニットとを有する、請求項1に記載の装置。
- 前記少なくとも一つの受光ユニットの第1の受光ユニットが前記刺激反応材料を通る反射光を受け、前記少なくとも一つの受光ユニットの第2の受光ユニットが前記刺激反応材料を通らない反射光を受ける、請求項10に記載の装置。
- 前記少なくとも一つの照明ユニットが前記刺激反応材料を通じて前記物質を照明する、請求項11に記載の装置。
- カテーテル又は針である、請求項1に記載の装置。
- 請求項10に記載の装置と、前記切除エネルギーを前記装置へ供給する少なくとも一つのエネルギー源と、前記得られた情報に基づいて、前記少なくとも一つのエネルギー源を調整するための制御ユニットとを有する、システム。
- 切除エネルギーを物質に供給するステップと、前記物質の温度が前記切断エネルギーのために上限温度を超えて増大する場合、前記物質の前記温度が温度限界を超えてまで増大しないように、刺激反応材料の状態を第1の状態から第2の状態へ変化させるステップとを有する、方法。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08160428.2 | 2008-07-15 | ||
| EP08160428 | 2008-07-15 | ||
| PCT/IB2009/053003 WO2010007564A2 (en) | 2008-07-15 | 2009-07-10 | Safe ablation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011528249A true JP2011528249A (ja) | 2011-11-17 |
| JP2011528249A5 JP2011528249A5 (ja) | 2012-08-30 |
| JP5649571B2 JP5649571B2 (ja) | 2015-01-07 |
Family
ID=41550781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011518045A Expired - Fee Related JP5649571B2 (ja) | 2008-07-15 | 2009-07-10 | 安全な切除 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9675417B2 (ja) |
| EP (1) | EP2320823B1 (ja) |
| JP (1) | JP5649571B2 (ja) |
| CN (1) | CN102098973B (ja) |
| WO (1) | WO2010007564A2 (ja) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019092843A (ja) * | 2017-11-22 | 2019-06-20 | 株式会社モリタ製作所 | レーザ伝送路、レーザ処置具、レーザ治療装置、及びレーザ治療システム |
| JP2021502869A (ja) * | 2017-11-14 | 2021-02-04 | ソニック・バスキュラー・インコーポレイテッドSonic Vascular, Inc. | 集束型腔内結石摘出カテーテル装置および方法 |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10499937B2 (en) | 2006-05-19 | 2019-12-10 | Recor Medical, Inc. | Ablation device with optimized input power profile and method of using the same |
| JP5649571B2 (ja) | 2008-07-15 | 2015-01-07 | コーニンクレッカ フィリップス エヌ ヴェ | 安全な切除 |
| EP2376011B1 (en) | 2009-01-09 | 2019-07-03 | ReCor Medical, Inc. | Apparatus for treatment of mitral valve insufficiency |
| US8702688B2 (en) * | 2009-10-06 | 2014-04-22 | Cardiofocus, Inc. | Cardiac ablation image analysis system and process |
| EP2683750B1 (en) * | 2011-03-09 | 2017-04-19 | Occlugel | Implantable swellable bio-resorbable polymer |
| US20140018793A1 (en) * | 2012-07-12 | 2014-01-16 | Covidien Lp | Heat-distribution indicators, thermal zone indicators, electrosurgical systems including same and methods of directing energy to tissue using same |
| US9439712B2 (en) | 2012-07-12 | 2016-09-13 | Covidien Lp | Heat-distribution indicators, thermal zone indicators, electrosurgical systems including same and methods of directing energy to tissue using same |
| US20140073907A1 (en) * | 2012-09-12 | 2014-03-13 | Convergent Life Sciences, Inc. | System and method for image guided medical procedures |
| EP3600107B1 (en) * | 2017-03-23 | 2022-03-23 | Medlogical Innovations Pty Ltd | Device for interstitial laser therapy |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002501628A (ja) * | 1997-05-30 | 2002-01-15 | カールソン、スティーブン、エー | 光シャッター素子 |
| JP2005227272A (ja) * | 2003-12-19 | 2005-08-25 | Ethicon Endo Surgery Inc | 改良された先端ディフューザーを有するレーザー装置用の光ファイバー及びその製造方法 |
| JP2011515142A (ja) * | 2008-03-21 | 2011-05-19 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 毛除去システム及び方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4307942A (en) * | 1974-05-20 | 1981-12-29 | The Southwall Corporation | Solar control system |
| CA2102884A1 (en) * | 1993-03-04 | 1994-09-05 | James J. Wynne | Dental procedures and apparatus using ultraviolet radiation |
| US6302878B1 (en) * | 1995-06-27 | 2001-10-16 | S.L.T. Japan Co., Ltd. | System for laser light irradiation to living body |
| US6508813B1 (en) * | 1996-12-02 | 2003-01-21 | Palomar Medical Technologies, Inc. | System for electromagnetic radiation dermatology and head for use therewith |
| EP0922715B8 (en) * | 1997-12-09 | 2008-05-21 | National Institute of Advanced Industrial Science and Technology | Stimuli-responsive polymer utilizing keto-enol tautomerization |
| US6562028B2 (en) * | 2000-06-12 | 2003-05-13 | Indigo Medical, Incorporated | Method of treating intervertebral discs by inserting a diffuser directly into the annulus |
| WO2003051286A2 (en) * | 2001-11-01 | 2003-06-26 | Regents Of The University Of Minnesota | Hydrogel compositions, devices, and microscale components |
| US6795464B2 (en) * | 2001-12-10 | 2004-09-21 | Spectra Systems Corporation | Temperature control of laser action in scattering media |
| US7135034B2 (en) * | 2003-11-14 | 2006-11-14 | Lumerx, Inc. | Flexible array |
| US7419486B2 (en) * | 2005-06-15 | 2008-09-02 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Treatment and diagnostic catheters with hydrogel electrodes |
| US8888684B2 (en) * | 2006-03-27 | 2014-11-18 | Boston Scientific Scimed, Inc. | Medical devices with local drug delivery capabilities |
| WO2008003642A1 (en) * | 2006-07-04 | 2008-01-10 | Bracco Imaging Spa | Device for localized thermal ablation of biological tissues, particularly tumoral tissues or the like |
| US20070224169A1 (en) * | 2006-07-18 | 2007-09-27 | Sliwa John W Jr | Selectively switched gels for surgery, therapy and maintenance |
| CN100540056C (zh) | 2006-11-03 | 2009-09-16 | 利芳建医药科技咨询(上海)有限公司 | 药物温敏水凝胶中空纤维的制备方法及其应用 |
| US9987221B2 (en) * | 2007-08-23 | 2018-06-05 | Boston Scientific Scimed, Inc. | Injectable hydrogel compositions |
| JP5649571B2 (ja) | 2008-07-15 | 2015-01-07 | コーニンクレッカ フィリップス エヌ ヴェ | 安全な切除 |
-
2009
- 2009-07-10 JP JP2011518045A patent/JP5649571B2/ja not_active Expired - Fee Related
- 2009-07-10 WO PCT/IB2009/053003 patent/WO2010007564A2/en not_active Ceased
- 2009-07-10 EP EP09786563.8A patent/EP2320823B1/en not_active Not-in-force
- 2009-07-10 CN CN2009801274472A patent/CN102098973B/zh not_active Expired - Fee Related
- 2009-07-10 US US13/003,022 patent/US9675417B2/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002501628A (ja) * | 1997-05-30 | 2002-01-15 | カールソン、スティーブン、エー | 光シャッター素子 |
| JP2005227272A (ja) * | 2003-12-19 | 2005-08-25 | Ethicon Endo Surgery Inc | 改良された先端ディフューザーを有するレーザー装置用の光ファイバー及びその製造方法 |
| JP2011515142A (ja) * | 2008-03-21 | 2011-05-19 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 毛除去システム及び方法 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021502869A (ja) * | 2017-11-14 | 2021-02-04 | ソニック・バスキュラー・インコーポレイテッドSonic Vascular, Inc. | 集束型腔内結石摘出カテーテル装置および方法 |
| JP2019092843A (ja) * | 2017-11-22 | 2019-06-20 | 株式会社モリタ製作所 | レーザ伝送路、レーザ処置具、レーザ治療装置、及びレーザ治療システム |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102098973B (zh) | 2013-08-14 |
| EP2320823B1 (en) | 2016-01-27 |
| WO2010007564A3 (en) | 2010-07-08 |
| WO2010007564A2 (en) | 2010-01-21 |
| US20110118714A1 (en) | 2011-05-19 |
| US9675417B2 (en) | 2017-06-13 |
| EP2320823A2 (en) | 2011-05-18 |
| CN102098973A (zh) | 2011-06-15 |
| JP5649571B2 (ja) | 2015-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5649571B2 (ja) | 安全な切除 | |
| Chicheł et al. | Hyperthermia–description of a method and a review of clinical applications | |
| EP3457971B1 (en) | Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue | |
| US11589920B2 (en) | Catheter with a double balloon structure to generate and apply an ablative zone to tissue | |
| US5045056A (en) | Method and device for thermal ablation of hollow body organs | |
| US20190224501A1 (en) | Acoustic applicators for controlled thermal modification of tissue | |
| EP0608609B1 (en) | Catheter for RF ablation with cooled electrode | |
| US20040167503A1 (en) | Malleable surgical ablation instruments | |
| JP2005504560A (ja) | 組織表面処置の装置および方法 | |
| WO2010151619A2 (en) | Devices, systems and methods for treatment of soft tissue | |
| KR20140022883A (ko) | 유체 강화 절제에서 요법을 성형하기 위한 장치 및 방법 | |
| US6064914A (en) | Thermotherapy method | |
| Sroka et al. | Endovenous laser application | |
| CN105615998B (zh) | 一种动脉粥样硬化靶向治疗装置 | |
| KR20100056440A (ko) | 환자 신체에 입자를 전달하는 시스템 및 방법 | |
| Häcker et al. | Minimally invasive treatment of renal cell carcinoma: comparison of 4 different monopolar radiofrequency devices | |
| Singal et al. | A review of therapeutic ablation modalities | |
| CN107224324A (zh) | 一种新型阵列微波消融针 | |
| Brunetaud et al. | Non-PDT uses of lasers in oncology | |
| Tianfu et al. | study of temperature changes around Fibres in Super Pulse Thulium Fibre laser in Vitro Lithotripsy | |
| Li et al. | Computational investigation on thermal responses of blood vessels during laser treatment of port wine stain | |
| Kho et al. | Saline-infused radiofrequency ablation: a review on the key factors for a safe and reliable tumour treatment | |
| US20060058705A1 (en) | Geometrically shaped hydrogel standoffs for coupling high intensity focused ultrasound | |
| Sturesson et al. | Tissue temperature control using a water‐cooled applicator: Implications for transurethral laser‐induced thermotherapy of benign prostatic hyperplasia | |
| US20260030999A1 (en) | Synthetic tissue models, materials, and methods for thermal treatment training and simulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120709 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120709 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130919 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131217 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140516 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140821 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20140829 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20141016 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20141111 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5649571 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |